Identification of early interactions between Francisella and the host

Infection and Immunity

Volumn 82, Issue 6, 2014, Pages 2504-2510

  Roberts, Lydia M ^a   Tuladhar, Shraddha ^a   Steele, Shaun P ^b   Riebe, Kristina J ^c   Chen, Ching Ju ^c   Ian Cumming, R ^c   Seay, Sarah ^c   Frothingham, Richard ^c   Sempowski, Gregory D ^c   Kawula, Thomas H ^b   Frelinger, Jeffrey A ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR; GREEN FLUORESCENT PROTEIN;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL LOAD; BONE MARROW CELL; CELL SUSPENSION; CONTROLLED STUDY; DENDRITIC CELL; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; FRANCISELLA NOVICIDA; FRANCISELLA TULARENSIS; HOST PATHOGEN INTERACTION; LUNG ALVEOLUS MACROPHAGE; LUNG INFECTION; MACROPHAGE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; REINFECTION; TULAREMIA; ANIMAL; BACTERIAL COUNT; C57BL MOUSE; DISEASE MODEL; IMMUNOLOGY; INTRANASAL DRUG ADMINISTRATION; LUNG; LUNG ALVEOLUS; MICROBIOLOGY;

ADAPTIVE IMMUNITY; ADMINISTRATION, INTRANASAL; ANIMALS; BACTERIAL LOAD; COLONY COUNT, MICROBIAL; DISEASE MODELS, ANIMAL; FRANCISELLA TULARENSIS; HOST-PATHOGEN INTERACTIONS; LUNG; MACROPHAGES; MICE; MICE, INBRED C57BL; NEUTROPHILS; PULMONARY ALVEOLI; TULAREMIA;

EID: 84900446473     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01654-13     Document Type: Article

References (28)

1. Moon JJ, Chu HH, Pepper M, McSorley SJ, Jameson SC, Kedl RM, Jenkins MK. 2007. Naive CD4(+) T cell frequency varies for different epitopes and predicts repertoire diversity and response magnitude. Immunity 27:203-213. http://dx.doi.org/10.1016/j.immuni.2007.07.007.
2. Woolard MD, Hensley LL, Kawula TH, Frelinger JA. 2008. Respiratory Francisella tularensis live vaccine strain infection induces Th17 cells and prostaglandin E2, which inhibits generation of gamma interferon-positive T cells. Infect. Immun. 76:2651-2659. http://dx.doi.org/10.1128/IAI.01412-07.
3. Pepper M, Linehan JL, Pagan AJ, Zell T, Dileepan T, Cleary PP, Jenkins MK. 2010. Different routes of bacterial infection induce long-lived TH1 memory cells and short-lived TH17 cells. Nat. Immunol. 11:83-89. http://dx.doi.org/10.1038/ni.1826.
4. Nurieva RI, Chung Y. 2010. Understanding the development and function of T follicular helper cells. Cell. Mol. Immunol. 7:190-197. http://dx.doi.org/10.1038/cmi.2010.24.
5. Anthony LS, Ghadirian E, Nestel FP, Kongshavn PA. 1989. The requirement for gamma interferon in resistance of mice to experimental tularemia. Microb. Pathog. 7:421-428. http://dx.doi.org/10.1016/0882-4010(89)90022-3.
6. Collazo CM, Sher A, Meierovics AI, Elkins KL. 2006. Myeloid differentiation factor-88 (MyD88) is essential for control of primary in vivo Francisella tularensis LVS infection, but not for control of intra-macrophage bacterial replication. Microbes Infect. 8:779-790. http://dx.doi.org/10.1016/j.micinf.2005.09.014.
7. Leiby DA, Fortier AH, Crawford RM, Schreiber RD, Nacy CA. 1992. In vivo modulation of the murine immune response to Francisella tularensis LVS by administration of anticytokine antibodies. Infect. Immun. 60:84-89.
8. Metzger DW, Salmon SL, Kirimanjeswara G. 2013. Differing effects of interleukin-10 on cutaneous and pulmonary Francisella tularensis live vaccine strain infection. Infect. Immun. 81:2022-2027. http://dx.doi.org/10.1128/IAI.00024-13.
9. Skyberg JA, Rollins MF, Samuel JW, Sutherland MD, Belisle JT, Pascual DW. 2013. Interleukin-17 protects against the Francisella tularensis live vaccine strain but not against a virulent F. tularensis type A strain. Infect. Immun. 81:3099-3105. http://dx.doi.org/10.1128/IAI.00203-13.
10. Oyston PC. 2009. Francisella tularensis vaccines. Vaccine 27(Suppl 4): D48-D51. http://dx.doi.org/10.1016/j.vaccine.2009.07.090.
11. Fortier AH, Green SJ, Polsinelli T, Jones TR, Crawford RM, Leiby DA, Elkins KL, Meltzer MS, Nacy CA. 1994. Life and death of an intracellular pathogen: Francisella tularensis and the macrophage. Immunol. Ser. 60: 349-361.
12. Metzger DW, Bakshi CS, Kirimanjeswara G. 2007. Mucosal immunopathogenesis of Francisella tularensis. Ann. N. Y. Acad. Sci. 1105:266-283. http://dx.doi.org/10.1196/annals.1409.007.
13. Fortier AH, Slayter MV, Ziemba R, Meltzer MS, Nacy CA. 1991. Live vaccine strain of Francisella tularensis: infection and immunity in mice. Infect. Immun. 59:2922-2928.
14. Hall JD, Woolard MD, Gunn BM, Craven RR, Taft-Benz S, Frelinger JA, Kawula TH. 2008. Infected-host-cell repertoire and cellular response in the lung following inhalation of Francisella tularensis Schu S4, LVS, or U112. Infect. Immun. 76:5843-5852. http://dx.doi.org/10.1128/IAI.01176-08.
15. Barrigan LM, Tuladhar S, Brunton JC, Woolard MD, Chen CJ, Saini D, Frothingham R, Sempowski GD, Kawula TH, Frelinger JA. 2013. Infection with Francisella tularensis LVS clpB leads to an altered yet protective immune response. Infect. Immun. 81:2028-2042. http://dx.doi.org/10.1128/IAI.00207-13.
16. Hall JD, Craven RR, Fuller JR, Pickles RJ, Kawula TH. 2007. Francisella tularensis replicates within alveolar type II epithelial cells in vitro and in vivo following inhalation. Infect. Immun. 75:1034-1039. http://dx.doi.org/10.1128/IAI.01254-06.
17. Bosio CM, Dow SW. 2005. Francisella tularensis induces aberrant activation of pulmonary dendritic cells. J. Immunol. 175:6792-6801.
18. Bosio CM, Bielefeldt-Ohmann H, Belisle JT. 2007. Active suppression of the pulmonary immune response by Francisella tularensis Schu4. J. Immunol. 178:4538-4547.
19. Leemans JC, Juffermans NP, Florquin S, van Rooijen N, Vervoordeldonk MJ, Verbon A, van Deventer SJ, van der Poll T. 2001. Depletion of alveolar macrophages exerts protective effects in pulmonary tuberculosis in mice. J. Immunol. 166:4604-4611.
20. Davis JK, Davidson MK, Schoeb TR, Lindsey JR. 1992. Decreased intrapulmonary killing of Mycoplasma pulmonis after short-term exposure to NO2 is associated with damaged alveolar macrophages. Am. Rev. Respir. Dis. 145:406-411. http://dx.doi.org/10.1164/ajrccm/145.2_Pt_1.406.
21. Gordon SB, Read RC. 2002. Macrophage defences against respiratory tract infections. Br. Med. Bull. 61:45-61. http://dx.doi.org/10.1093/bmb/61.1.45.
22. Nash TW, Libby DM, Horwitz MA. 1984. Interaction between the legionnaires' disease bacterium (Legionella pneumophila) and human alveolar macrophages. Influence of antibody, lymphokines, and hydrocortisone. J. Clin. Invest. 74:771-782.
23. Guth AM, Janssen WJ, Bosio CM, Crouch EC, Henson PM, Dow SW. 2009. Lung environment determines unique phenotype of alveolar macrophages. Am. J. Physiol. Lung Cell Mol. Physiol. 296:L936-L946. http://dx.doi.org/10.1152/ajplung.90625.2008.
24. Cheung DO, Halsey K, Speert DP. 2000. Role of pulmonary alveolar macrophages in defense of the lung against Pseudomonas aeruginosa. Infect. Immun. 68:4585-4592. http://dx.doi.org/10.1128/IAI.68.8.4585-4592.2000.
25. Hickman-Davis JM, Michalek SM, Gibbs-Erwin J, Lindsey JR. 1997. Depletion of alveolar macrophages exacerbates respiratory mycoplasmosis in mycoplasma-resistant C57BL mice but not mycoplasma-susceptible C3H mice. Infect. Immun. 65:2278-2282.
26. Broug-Holub E, Toews GB, van Iwaarden JF, Strieter RM, Kunkel SL, Paine R, III, Standiford TJ. 1997. Alveolar macrophages are required for protective pulmonary defenses in murine Klebsiella pneumonia: elimination of alveolar macrophages increases neutrophil recruitment but decreases bacterial clearance and survival. Infect. Immun. 65:1139-1146.
27. Wu TH, Hutt JA, Garrison KA, Berliba LS, Zhou Y, Lyons CR. 2005. Intranasal vaccination induces protective immunity against intranasal infection with virulent Francisella tularensis biovar A. Infect. Immun. 73: 2644-2654. http://dx.doi.org/10.1128/IAI.73.5.2644-2654.2005.
28. Conlan JW, Shen H, Kuolee R, Zhao X, Chen W. 2005. Aerosol-, but not intradermal-immunization with the live vaccine strain of Francisella tularensis protects mice against subsequent aerosol challenge with a highly virulent type A strain of the pathogen by an alphabeta T cell-and interferon gamma-dependent mechanism. Vaccine 23:2477-2485. http://dx.doi.org/10.1016/j.vaccine.2004.10.034.